Robert A. Schwartzman

Array ( [id] => 3983509 [patent_doc_number] => 05861381 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Pharmaceutical composition for the treatment of a malignant tumor' [patent_app_type] => 1 [patent_app_number] => 8/479537 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7007 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 308 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861381.pdf [firstpage_image] =>[orig_patent_app_number] => 479537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361473 [patent_doc_number] => 06191257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Natural or recombinant DNA binding proteins as carriers for gene transfer or gene therapy' [patent_app_type] => 1 [patent_app_number] => 8/480935 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6922 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/191/06191257.pdf [firstpage_image] =>[orig_patent_app_number] => 480935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799775 [patent_doc_number] => 05830462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Regulated transcription of targeted genes and other biological events' [patent_app_type] => 1 [patent_app_number] => 8/478386 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 37 [patent_no_of_words] => 37037 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 43 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830462.pdf [firstpage_image] =>[orig_patent_app_number] => 478386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3804339 [patent_doc_number] => 05853985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-29 [patent_title] => 'Promoter of the gene for the human precursor of the alzheimer\'s disease and its use' [patent_app_type] => 1 [patent_app_number] => 8/483488 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2345 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/853/05853985.pdf [firstpage_image] =>[orig_patent_app_number] => 483488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221599 [patent_doc_number] => 06010901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Salmonella virulence genes' [patent_app_type] => 1 [patent_app_number] => 8/475749 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 21831 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010901.pdf [firstpage_image] =>[orig_patent_app_number] => 475749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767533 [patent_doc_number] => 05733726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Cytotoxicity-based genetic selection system (TOXSEL)' [patent_app_type] => 1 [patent_app_number] => 8/472238 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 12 [patent_no_of_words] => 8431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733726.pdf [firstpage_image] =>[orig_patent_app_number] => 472238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734892 [patent_doc_number] => 05753263 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Method to deliver compositions conferring resistance to alopecia to hair follicles' [patent_app_type] => 1 [patent_app_number] => 8/486520 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 37 [patent_no_of_words] => 26149 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753263.pdf [firstpage_image] =>[orig_patent_app_number] => 486520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177292 [patent_doc_number] => 06019980 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-01 [patent_title] => 'Nucleic acid respiratory syncytial virus vaccines' [patent_app_type] => 1 [patent_app_number] => 8/476397 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9529 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/019/06019980.pdf [firstpage_image] =>[orig_patent_app_number] => 476397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3693493 [patent_doc_number] => 05650308 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Recombinant Bacillus thuringiensis strain construction method' [patent_app_type] => 1 [patent_app_number] => 8/478585 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14421 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 227 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650308.pdf [firstpage_image] =>[orig_patent_app_number] => 478585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034002 [patent_doc_number] => 05856185 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Method for making reflection defective retroviral vectors for infecting human cells' [patent_app_type] => 1 [patent_app_number] => 8/472109 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 54 [patent_no_of_words] => 36987 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856185.pdf [firstpage_image] =>[orig_patent_app_number] => 472109 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3758795 [patent_doc_number] => 05851796 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes' [patent_app_type] => 1 [patent_app_number] => 8/474169 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 37 [patent_no_of_words] => 13609 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/851/05851796.pdf [firstpage_image] =>[orig_patent_app_number] => 474169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4393885 [patent_doc_number] => 06297048 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-02 [patent_title] => 'Hepatitis therapeutics' [patent_app_type] => 1 [patent_app_number] => 8/483511 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 37886 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/297/06297048.pdf [firstpage_image] =>[orig_patent_app_number] => 483511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3741150 [patent_doc_number] => 05716613 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Recombinant retroviruses' [patent_app_type] => 1 [patent_app_number] => 8/474736 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 31 [patent_no_of_words] => 24519 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/716/05716613.pdf [firstpage_image] =>[orig_patent_app_number] => 474736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109197 [patent_doc_number] => 06022950 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Hybrid molecules having translocation region and cell-binding region' [patent_app_type] => 1 [patent_app_number] => 8/479510 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 8847 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022950.pdf [firstpage_image] =>[orig_patent_app_number] => 479510 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3730662 [patent_doc_number] => 05652337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-29 [patent_title] => 'OP-3-induced morphogenesis' [patent_app_type] => 1 [patent_app_number] => 8/479666 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23592 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/652/05652337.pdf [firstpage_image] =>[orig_patent_app_number] => 479666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3905391 [patent_doc_number] => 06001350 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Genetic modification of endothelial cells' [patent_app_type] => 1 [patent_app_number] => 8/488420 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 32 [patent_no_of_words] => 16776 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001350.pdf [firstpage_image] =>[orig_patent_app_number] => 488420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221709 [patent_doc_number] => 06010908 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Gene therapy by small fragment homologous replacement' [patent_app_type] => 1 [patent_app_number] => 8/487799 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 38 [patent_no_of_words] => 35459 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010908.pdf [firstpage_image] =>[orig_patent_app_number] => 487799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4031351 [patent_doc_number] => 05994313 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Regulated apoptosis' [patent_app_type] => 1 [patent_app_number] => 8/483898 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 32 [patent_no_of_words] => 41828 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994313.pdf [firstpage_image] =>[orig_patent_app_number] => 483898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3791308 [patent_doc_number] => 05726058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Syndecan stimulation of cellular differentiation' [patent_app_type] => 1 [patent_app_number] => 8/472217 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 28 [patent_no_of_words] => 8401 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726058.pdf [firstpage_image] =>[orig_patent_app_number] => 472217 [rel_patent_id] =>[rel_patent_doc_number] =>)